Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for September 2024.
Category
Research
-
-
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Tenecteplase for Ischemic Stroke at 4.5 to 24 Hours without Thrombectomy
August 7, 2024Our paper of the month for August is a randomised controlled trial evaluating tenecteplase administered 4.5 to 24 hours after stroke onset in 516 Chinese patients. -
Research HighlightsEAN NewsFeatured Slider
Research Highlights of the Month – August 2024
August 7, 2024Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for August 2024. -
The European Platform for Neurodegenerative Diseases project has launched an open call for expressions of interest to leverage biosamples and datasets catalogued on its platform.
-
Results of a short survey conducted among EAN panel members about their competence, interest, and knowledge of the new connectomics methods for studying clinical conditions
-
EAN NewsResearch
EAN NEuro-covid ReGistrY (ENERGY) reaches 4,000 patients and welcomes interested parties for statistical analyses.
July 24, 2024An update on the ENERGY project, which has to date welcomed 96 principal investigators and project members from 44 centres, mainly located in Europe, and included data for more than 4,000 patients. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Sleep, 24-Hour Activity Rhythms, and Subsequent Amyloid-β Pathology
July 18, 2024Our paper of the month is an observational cohort study exploring the link between sleep measures and AD pathology in 319 participants (mean ± SD age: 61.5 ± 5.4 years; 47% female) from the Rotterdam Study, a prospective population-based study conducted in the Netherlands. -
Research HighlightsEAN NewsFeatured Slider
Research Highlights of the Month – July 2024
July 18, 2024Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for July 2024. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Ghrelin for Neuroprotection in Post-Cardiac Arrest Coma
June 5, 2024Our paper of the month reports the result of a trial investigating the safety and the potential efficacy of intravenous treatment with acyl-ghrelin in improving neurological outcome in patients in a coma after cardiac arrest. -
Research HighlightsEAN NewsFeatured Slider
Research Highlights of the Month – June 2024
June 5, 2024Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for June 2024. -
ResearchSurveys
Survey: Mapping European Neurological Programs in Solid Organ Transplant Centers
May 31, 2024Complete our short survey exploring the involvement of neurologists in evaluating Solid Organ Transplant candidates and managing post-transplant complications. -
Paper of the MonthEAN NewsFeatured Slider
Research Paper of the Month: Biomarker Changes during 20 Years Preceding Alzheimer’s Disease
May 7, 2024In our Paper of the Month for May, researchers traced the trajectory of Alzheimers biomarkers, for the first time employing a longitudinal design, with impressive, groundbreaking results. -
Each month the EANpages editorial team reviews the scientific press for recently published papers of outstanding interest to neurologists. Here we present our selection for May 2024.
-
The new Horizon Europe Strategic Plan (2025-27) has set out the policy priorities related to research funding in the European Union for the next three years.
-
ResearchEur J Neurol
EAN publishes first ALS guideline in collaboration with European Reference Network for Neuromuscular Diseases
April 4, 2024The EAN has published a new guideline on the management of ALS in collaboration with the European Reference Network for Neuromuscular Diseases.